Benjamin T.
- Country
- France
- Department
- Internal Medicine Department
Research Overview
- Evaluation of Rituximab-Based Combination, Tocilizumab, and Tofacitinib in Granulomatosis with Polyangiitis Patients Unresponsive to Standard Therapy
- Phase 2, Randomized, Double-Blind, Placebo-controlled, Parallel-Group, Multicenter Study to Evaluate the Safety and Efficacy of Tarperprumig in Adult Participants with Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Data & Insights
Has run more than one trial at 4 of 48 partner sites.
Specializations
Vasculitis Disorders
This investigator specializes in various forms of vasculitis, with particular focus on ANCA-associated vasculitis and eosinophilic granulomatosis with polyangiitis (EGPA). Their research extends to evaluating novel therapeutic approaches for Takayasu arteritis and giant cell arteritis.
- ANCA-associated renal vasculitis treatments
- EGPA therapeutic interventions
- Large vessel vasculitis management
Autoimmune Conditions
The investigator conducts research in various autoimmune disorders, including Behçet's disease uveitis and dermatomyositis. Their work encompasses innovative therapeutic approaches for non-infectious uveitis and complex inflammatory conditions.
- Biological therapy applications
- Inflammatory disease management
- Therapeutic drug monitoring
Novel Therapeutic Approaches
The investigator explores innovative treatment strategies including targeted therapies and biological agents. Their research includes evaluation of various therapeutic compounds for treating resistant inflammatory conditions.
- Personalized treatment strategies
- Biologic therapy optimization
- Glucocorticoid-sparing treatments
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.